Cian Healthcare Q2 Results
- BSE: 542678
- NSE: -
- ISIN: INE05BN01019
- Sector: Biotechnology & Drugs
BSE
5.01
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Tue 20 Jan, 2026 | 07:47:07
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹11.32 Cr.(-40.08%)
- Operating Profit₹-5.87 Cr.(-63.12%)
- Profit After Tax₹-5.32 Cr.(-70.84%)
- Operating Margin-51.83%(NA%)
Note: Comparison is on YoY basis
Quarterly - Cian Healthcare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 17.19 | - | N/A | 30.87 | -50.61% |
| Depreciation/ Amortization | 1.96 | - | N/A | 2.72 | -19.58% |
| Operating Income | -5.87 | - | N/A | 1.75 | -63.12% |
| Net Income | -5.32 | - | N/A | -1.48 | -70.84% |
| Other Operating Expenses Total | 1.10 | - | N/A | 2.99 | -54.97% |
| Net Income Before Taxes | -5.25 | - | N/A | -1.08 | -71.24% |
| Total Revenue | 11.32 | - | N/A | 32.61 | -40.08% |
| Selling/ General/ Admin Expenses Total | 3.73 | - | N/A | 6.79 | -38.24% |
| Diluted Normalized EPS | -42.57 | - | N/A | -11.80 | -14.14% |